van Eden W - Search Results

1

Induction of T cell anergy by liposomes with incorporated major histocompatibility complex (MHC) II/peptide complexes.

van Rensen AJ, Taams LS, Grosfeld-Stulemeyer MC, van Eden W, Crommelin DJ, Wauben MH. van Rensen AJ, et al. Among authors: van eden w. Pharm Res. 2000 Jun;17(6):720-6. doi: 10.1023/a:1007586400631. Pharm Res. 2000. PMID: 10955847

2

Effector and regulatory T cells derived from the same T cell clone differ in MHC class II-peptide multimer binding.

Nolte-'t Hoen EN, Amoroso MG, Veenstra J, Grosfeld-Stulemeyer MC, van Eden W, Broeren CP, Wauben MH. Nolte-'t Hoen EN, et al. Among authors: van eden w. Eur J Immunol. 2004 Dec;34(12):3359-69. doi: 10.1002/eji.200425563. Eur J Immunol. 2004. PMID: 15549773 Free article.

3

Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone.

Wauben MH, Boog CJ, van der Zee R, Joosten I, Schlief A, van Eden W. Wauben MH, et al. Among authors: van der zee r, van eden w. J Exp Med. 1992 Sep 1;176(3):667-77. doi: 10.1084/jem.176.3.667. J Exp Med. 1992. PMID: 1380974 Free PMC article.

4

Anergic T cells actively suppress T cell responses via the antigen-presenting cell.

Taams LS, van Rensen AJ, Poelen MC, van Els CA, Besseling AC, Wagenaar JP, van Eden W, Wauben MH. Taams LS, et al. Among authors: van eden w, van els ca, van rensen aj. Eur J Immunol. 1998 Sep;28(9):2902-12. doi: 10.1002/(SICI)1521-4141(199809)28:09<2902::AID-IMMU2902>3.0.CO;2-B. Eur J Immunol. 1998. PMID: 9754577

5

Dose-dependent induction of distinct anergic phenotypes: multiple levels of T cell anergy.

Taams LS, van Eden W, Wauben MH. Taams LS, et al. Among authors: van eden w. J Immunol. 1999 Feb 15;162(4):1974-81. J Immunol. 1999. PMID: 9973467

6

Liposomes with incorporated MHC class II/peptide complexes as antigen presenting vesicles for specific T cell activation.

van Rensen AJ, Wauben MH, Grosfeld-Stulemeyer MC, van Eden W, Crommelin DJ. van Rensen AJ, et al. Among authors: van eden w. Pharm Res. 1999 Feb;16(2):198-204. doi: 10.1023/a:1018864005620. Pharm Res. 1999. PMID: 10100303

7

Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions.

Taams LS, van Eden W, Wauben MH. Taams LS, et al. Among authors: van eden w. Eur J Immunol. 1999 May;29(5):1543-50. doi: 10.1002/(SICI)1521-4141(199905)29:05<1543::AID-IMMU1543>3.0.CO;2-R. Eur J Immunol. 1999. PMID: 10359108 Free article.

8

'Anergic' T cells modulate the T-cell activating capacity of antigen-presenting cells.

Taams LS, Boot EP, van Eden W, Wauben MH. Taams LS, et al. Among authors: van eden w. J Autoimmun. 2000 Jun;14(4):335-41. doi: 10.1006/jaut.2000.0372. J Autoimmun. 2000. PMID: 10882060

9

Identification of a CD4+CD25+ T cell subset committed in vivo to suppress antigen-specific T cell responses without additional stimulation.

Nolte-'t Hoen EN, Wagenaar-Hilbers JP, Boot EP, Lin CH, Arkesteijn GJ, van Eden W, Taams LS, Wauben MH. Nolte-'t Hoen EN, et al. Among authors: van eden w. Eur J Immunol. 2004 Nov;34(11):3016-27. doi: 10.1002/eji.200324725. Eur J Immunol. 2004. PMID: 15376196 Free article.

10

Uptake of membrane molecules from T cells endows antigen-presenting cells with novel functional properties.

Nolte-'t Hoen EN, Wagenaar-Hilbers JP, Peters PJ, Gadella BM, van Eden W, Wauben MH. Nolte-'t Hoen EN, et al. Among authors: van eden w. Eur J Immunol. 2004 Nov;34(11):3115-25. doi: 10.1002/eji.200324711. Eur J Immunol. 2004. PMID: 15459903 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

286 results

Search Page

Filters